Jan Baros

To the Editor, Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of subcutaneous or submucosal swelling caused by dysregulation of the kallikrein–kinin system and excessive bradykinin production [1]. Acute attacks are treated with on-demand therapies including plasma-derived or recombinant C1-inhibitor concentrates and the bradykinin B2-receptor antagonist icatibant [1].

6.5. Further Research After augmenting the CICS platform with the cRIO-9039 controller, the next area of research is a more detailed evaluation of experimental measurements such as convergence time, algorithm stability, computational complexity, response to different types of transients and ability to operate under different distribution network conditions.